![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 51, 36465-36471, December 17, 1999
-Ketoacyl-Acyl Carrier Protein Synthase
III
,From SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406
| |
ABSTRACT |
|---|
|
|
|---|
Condensing enzymes catalyze carbon-carbon bond formation by
condensing an acyl primer with an elongating carbon source often attached to a holo-acyl carrier protein
(ACP).1 These enzymes act
either as single polypeptides or domains of multienzyme complexes. They
are responsible for the biosynthesis of a diverse set of natural
products, including fatty acids (1, 2) and polyketides (3), and have
recently been used to catalyze the synthesis of "unnatural"
compounds (4, 5). Three condensing enzymes are involved in bacterial
fatty acid biosynthesis: FabB, FabF, and FabH ( Protein Purification and Crystallization--
Native E. coli FabH protein was overexpressed in E. coli DH10B
cells using the pET29 (Novagen) vector and purified to homogeneity in
three chromatographic steps (Q-Sepharose, MonoQ, and hydroxyapatite) at
4 °C. The selenomethionine-substituted protein was expressed in
E. coli BL21 cells and purified in a similar way. Apo FabH crystals were obtained with the native protein using 20% polyethylene glycol 8000 at neutral pH, whereas the acetyl-CoA complex crystals were
obtained with the selenomethionine protein using saturating acetyl-CoA
and 14% polyethylene glycol 6000 at neutral pH. Crystals were ~0.3
mm in size and were frozen before data collection.
Data Collection and Multiple-wavelength Anomalous Dispersion
Phasing--
Diffraction data from the apo crystal were measured to
2.0 Å resolution at the Industrial Macromolecular Crystallography
Association 17-ID beam line at the Advanced Photon Source (Table
I). The crystal was of the orthorhombic
P212121 space group with cell dimensions a = 63.1, b = 65.1, and
c = 166.5 Å, with one FabH dimer per asymmetric unit.
The selenomethionine FabH·acetyl-CoA complex crystal belongs to the
tetragonal space group P41212, with
a = b = 72.4 and c = 102.8 Å, and contains a monomer per asymmetric unit. The data (Table
I), obtained at the X12C beam line of the Brookhaven National
Laboratory, were measured at three wavelengths optimal for Se
multiple-wavelength anomalous dispersion phasing experiments. Although
the crystal mosaicity was as high as 1.4o (compared with
that of 0.7o for the apo crystal) and the data were only
80% complete, the data quality was improved by its high redundancy.
The acetyl-CoA complex structure was determined to 1.9-Å resolution
using the multiple-wavelength anomalous dispersion phasing technique
with the program SOLVE (16). There are 8 methionines in E. coli FabH; all were correctly located by SOLVE and refined to
reasonable occupancies (0.62-1.00) and temperature factors (23 -41 Å2). The overall figure of merit was 0.6 from 30 to 1.9 Å resolutions, and the overall Z score was 148. The resulting
electron density map was of very high quality (Fig.
1).
Model Building and Refinement--
The whole FabH protein (317 residues), the bound acetyl and CoA, as well as 98 solvent molecules
were built in the initial model. The data set collected at the
inflection point wavelength (0.9785) (I > 2 Overall Structure: E. coli--
FabH displays a five-layered core
structure, Structure of the Dimer--
The crystal structure of FabH revealed
the presence of a tight dimer (Fig. 3),
consistent with our biochemical
data3 and similar to the
structures of FabF (22, 23) and thiolase I (24, 25). The dimer
interface mainly involves Nb3, Na3, and Na2 and buries ~2670
Å2 of accessible surface area. Strand Nb3 of one monomer
interacts with that of the other monomer to form a continuous
10-stranded Catalytic Residues--
Each FabH active site, located at the
center of the monomer, is formed at the interface of the N- and
C-terminal domains (Fig. 2A). The catalytic residues in
thiolase I were proposed to be Cys125, His375,
and Cys403 (24, 25), whereas those in FabF were predicted
to be Cys163, His303, and His340
(22, 23). The corresponding residues in FabH were found by structural
alignment to be Cys112, His244, and
Asn274. Although FabH Cys112 aligns well with
Cys163 of FabF and Cys125 of thiolase I, the
structural superposition revealed significant differences among other
catalytic residues (Fig. 4). The lack of
a Cys403-like residue in FabH implies a role for that
residue that is relevant only to the thiolase reaction.
Asn274 superimposes well with the histidines in FabF
(His340) and thiolase I (His375), but
His244 is far from its counterpart (His303) in
FabF, suggesting different substrate specificity. A previously unsuspected thiolase residue, Asn343, is found near
His244 of FabH. If Asn343 plays a role in
catalysis, it is possible that the His-Asn pairs of FabH and thiolase
are inverted structurally to match the reversed reactions they
catalyze.
Substrate or Ligand Binding--
Both FabF and thiolase I
structures were determined in the absence of a substrate; thus, the
structural basis for catalysis and substrate specificity has not been
established. To further investigate these important questions, we
co-crystallized FabH with its first substrate, acetyl-CoA. The overall
structure of FabH in the acetyl-CoA complex agrees well with the apo
structure, with a r.m.s. difference of 0.3 Å for all 317
Surprisingly, we found a CoA molecule bound in the acetyl-CoA complex,
although the electron density is weak for parts of the molecule (Fig.
5B). Observing CoA in the crystal suggests that the reaction
product has a notable FabH affinity. The bound CoA allows us to define
the active site cavity, which is long (~15 Å) and narrow, ideal for
fitting the pantetheine group of substrates in a more or less extended
conformation. The adenine ring of CoA stacks between the side chains of
Trp32 and Arg151 (Fig. 5C), a
classical adenine binding mode. The Arg151 side chain also
interacts with the ribose hydroxyl (3.4 Å) and phosphate (3.2 Å),
whereas the N-cap dipole of helix Cb1 and Arg36 are
involved in stabilizing the diphosphate. The pantetheine group
interacts with the hydrophobic wall of the active site cavity, comprised of residues such as Ile156, Met207,
Val212, Phe213, and Ile250. The
pantothenate also forms a couple of hydrogen bonds (O9 to Asn247 ND2, 2.9 Å; N8 to Gly209 O, 3.1 Å)
with the enzyme, but the It has been shown that FabH can accept primers such as acetyl-,
propionyl-, and butyryl-CoA, but not long chain acyl-CoA (7, 8). This
is supported by our FabH structure, in which the primer binding pocket
is indeed quite small (Fig. 5A). The acetyl methyl group
takes up most of the space in this pocket and is within reasonable van
der Waals distances to Leu142, Phe157, and
Phe87'. It is possible to model an additional carbon
pointing between the side chains of Leu189 and
Phe157, suggesting a propionyl group can also fit. Adding
yet another carbon appears to require side chain rearrangements,
consistent with a much reduced efficiency for butyryl-CoA. This is in
contrast to the FabF primer binding pocket that is much more extended
and is the locus of binding of cerulenin (23). A helical segment of
FabF (Phe133-Ile138) is found by structural
analogy to play a role similar to FabH Phe87', suggesting
the use of dimer interface as a conserved feature in condensing enzymes
to modulate primer specificity. It is clear from structural inspection
that cerulenin or a long acyl chain would not bind the FabH enzyme
because the pocket is too small.
Although our acetyl-CoA structure turns out to be a product complex,
the observed CoA provides a basis for modeling either of the FabH
substrates. As indicated by the nature of the interactions, the mode of
CoA binding should approximate that of the acetyl-CoA from adenine to
most of the pantothenate. The observed flexible CoA tail is probably
not an accurate representation of acetyl-CoA, but the substrate binding
mode can be modeled with only a few free bond rotations. In such a
model, this tail is probably in a more extended conformation. The
hydrogen bonds between the acetyl carbonyl oxygen and the backbone
nitrogens of Gly306 and Cys112 may guide the
acetyl group into the active site, positioning it for nucleophilic
attack by Cys112 (Fig.
6A). His244, 3.4 Å from Cys112, is in position to act as a general base and
extract a proton from Cys112. Asn274
is too far (4.2 Å from Cys112) to assume this role.
The side chain of Ser276 is 3.8 Å from Cys112,
but its nature prohibits it from accepting a proton. The reaction likely goes through a tetrahedral intermediate, with the carbonyl group
forming an oxyanion. The backbone nitrogens of Gly306 and
Cys112 can stabilize this oxyanion. After the acetyl
transfer to Cys112, His244 could replenish the
CoA sulfur with a proton to produce a neutral CoA (Fig. 6A).
In well-known examples such as serine proteases, catalytic residues can
be superimposed regardless of large differences in the overall protein
folding (26). However, His244 and its analogous residue in
FabF (His303) are in different positions with respect to
the catalytic cysteines (Fig. 4). This is most likely attributable to
differences in the substrates, suggesting that the histidine may
interact directly with substrates or intermediates in addition to its
role as the catalytic base. The positional differences in the catalytic
apparatus suggest that condensing enzymes are under stringent
evolutionary pressure to recognize and process different substrates,
another reason for their sequence divergence.
-Ketoacyl-acyl carrier protein synthase III
(FabH), the most divergent member of the family of condensing enzymes,
is a key catalyst in bacterial fatty acid biosynthesis and a promising target for novel antibiotics. We report here the crystal structures of
FabH determined in the presence and absence of acetyl-CoA. These
structures display a fold that is common for condensing enzymes. The
observed acetylation of Cys112 proves its catalytic
role and clearly defines the primer binding pocket. Modeling based on a
bound CoA molecule suggests catalytic roles for His244 and
Asn274. The structures provide the molecular basis for FabH
substrate specificity and reaction mechanism and are important for
structure-based design of novel antibiotics.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-ketoacyl-ACP
synthase I, II, and III, respectively). Each catalyzes a distinct
biochemical reaction (1, 2). FabH plays a central role in fatty acid
synthesis because it catalyzes the initiating condensation reaction and
is responsible for the feedback regulation of the pathway via product
(palmitoyl-ACP) inhibition (6-9). FabH catalyzes the condensation of
acetyl-CoA and malonyl-ACP to yield acetoacetyl-ACP. The reaction is
believed to occur in three steps: the acetyl transfer from acetyl-CoA
to a catalytic cysteine, the decarboxylation of malonyl-ACP to form a
carbanion, and the condensation of the acetyl group and carbanion (1,
2). FabH most likely acts as a homodimer of ~70 kDa (10, 11). In a
similar manner to other components of the dissociated (type II) fatty
acid synthase system, FabH exists as an isolated enzyme. In
vertebrates, however, this enzymatic activity is encoded in the N
terminus of a large multi-functional Type I fatty acid synthase, which
displays no overall sequence homology to the bacterial enzyme. Emerging
resistance to currently used antibacterial agents has generated an
urgent need for antibiotics acting via novel mechanisms (12, 13). FabH
exists ubiquitously in bacteria and is essential for
viability,2 suggesting it is
a potential broad-spectrum antibacterial target. Moreover,
thiolactomycin has been shown to be an effective inhibitor of bacterial
condensing enzymes; it also possesses antibacterial activity (1, 2).
The significant differences between bacterial and human fatty acid
synthase systems suggest great potential for specific and selective
inhibition. Most condensing enzymes contain a consensus sequence of 45 amino acids, but FabH is the most divergent member of the family and
matches few of the consensus residues (14). The antibiotic cerulenin
inhibits almost all condensing enzymes but not FabH (15). Thus, FabH
could have a fold and evolutionary origin different from other
condensing enzymes. Here we report the crystal structure of
Escherichia coli FabH in the presence and absence of ligand
and show that the enzyme contains a quasi-2-fold symmetry, most likely
resulting from gene duplication. The structures suggest a conserved
fold for all condensing enzymes, provide the structural basis for the
catalytic mechanism, and will serve as molecular templates for
structure-based drug design.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Structure determination and refinement statistics

View larger version (44K):
[in a new window]
Fig. 1.
Experimentally (MAD) phased
electron density map at Tyr125 in a cross-eye stereo
view. The map is contoured at 1.5
, and Tyr125 is
from the refined model. The extra electron density near the main chain
atoms of Tyr125 belongs to the backbone atoms of the
neighboring residues.
[I]) were used for structural refinement with XPLOR
(17) because its completion is the highest among the three. The apo
FabH structure (P212121) was solved
using the molecular replacement program AMORE (18) with the protein
atoms from the acetyl-CoA complex structure as the search model. The
two monomers were identified, and the solution gave an
R-factor of 33% (8.0-3.5 Å). The model was initially
built using the 2-fold averaged electron density map and refined to the
final model using XPLOR. Both models (Table I) have good geometry with
no Ramachandran outliers. The apo structure is clearly of good quality,
as indicated by the low R-factors; the acetyl-CoA complex
structure is also valid for the discussions in this report. This is
because the high-quality electron density map (Fig. 1) is calculated
from experimental phases; the complex structure has been used
successfully to solve the apo structure; and the two structures are
practically the same at
-carbon level (r.m.s., 0.3 Å). We have not
included the Se atoms and their anomalous signal in the current stage
of refinement, resulting in the slightly higher R-factors of
the complex structure. The figures were created with the computer
programs XTALVIEW (19), MOLSCRIPT (20), and GRASP (21).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-
-
-
-
, where each
comprises two
-helices and each
is made of a five-stranded, mixed
-sheet
(Fig. 2A). Despite the lack of
overall sequence homology, the FabH core structure is similar to that
of FabF, the other condensing enzyme of known structure (22, 23). This fold was first identified in thiolase I, which catalyzes the
degradation of ketoacyl-CoA structure (24, 25). The superposition of
the FabH and FabF cores results in a r.m.s. difference of 1.7 Å for 160 pairs of
-carbon atoms. In the comparison, Na2, Ca2, Cb3, and
part of Ca3 were excluded because of large differences. The structures
beyond the cores fold into a domain for substrate recognition (Fig.
2A) and intermolecular interactions, and this domain is completely unrelated to that of FabF or thiolase. The overall sequence
identity is only 14% between FabH and FabF, but the 160 pairs of
structurally matched residues have a higher sequence identity of 21%,
indicating that FabH is evolutionally related to FabF. Because FabF
fits well with the consensus sequence (14), our results suggest a
common ancestor for all condensing enzymes. Their sequences and
peripheral structures have diverged significantly throughout evolution
to accommodate the differences in substrates. The FabH monomer appears
to have been generated through gene duplication. The two halves,
residues 1-170 and 171-317, have only 11% overall sequence identity.
However, their structures are similar except for the insertion and loop
regions (Fig. 2B). The best matched structural elements of
the two FabH halves are strands b1, b2, b4, and b5. Within these
strands, the 33 pairs of
-carbons can be superimposed with a r.m.s.
difference of only 1.0 Å, and the sequence identity between them is as
high as 24%. A search of sequence data bases revealed no homologous
proteins half the size of FabH, except for a few hypothetical proteins
deduced from DNA sequences.

View larger version (37K):
[in a new window]
Fig. 2.
Overall structure of E. coli
FabH. A, ribbon diagram of the FabH monomer. The
N-terminal (1-170) and C-terminal (171-317) halves have a similar
fold. The core secondary structural elements are labeled as
b1-b5 and a1-a3, respectively and referred in
the text with a prefix of N or C to indicate the
domain they belong to. These
-sheet and
-helices are drawn in
magenta (N, b1-b5), cyan (N,
a1-a3), red (C, b1-b5), and
blue (C, a1-a3). N is the N terminus,
which precedes N, b1. C is the C terminus, which
comes off C, b5. Secondary elements of insertion regions are
drawn in yellow and orange for N- and C-terminal
domains, respectively. The catalytic Cys112 is shown in a
red ball-and-stick drawing, and the CoA molecule
(green) was taken from the acetyl-CoA complex structure to
orient the view. B, stereo view of the superposition between
the N-terminal (red) and C-terminal (blue)
domains of FabH. Core
-strands are labeled; the overlay was
generated by matching the 33
-carbon pairs from four of the
strands.
-sheet in the dimer. Helix Na3, with the catalytic
Cys112 near its N terminus (Gly114), uses its
C-terminal half to interact with its counterpart from the other
monomer. This suggests that the dimer interface is important for
positioning the catalytic apparatus of FabH. The two active sites,
facing opposite sides in the dimer, are formed mostly by residues
within each monomer. However, Phe87 (in a loop preceding helix Na2) of
one monomer projects into the active site of the other monomer. These
structural features suggest that the observed dimer is the biologically
relevant structure, and that its formation is essential for the proper
functioning of the FabH enzyme.

View larger version (71K):
[in a new window]
Fig. 3.
Ribbon diagram of the FabH dimer. The
dimer is viewed perpendicular to the two-fold axis. One monomer is
shown in yellow and green; the other is shown in
cyan and magenta. Phe87 and
Cys112 (red) are shown as ball-and-stick
models.

View larger version (38K):
[in a new window]
Fig. 4.
Superposition of potential catalytic residues
in FabH (red), FabF (blue), and
thiolase I (yellow). FabH residues are labeled.
The corresponding residues in FabF are Cys163,
His303, and His340, and those in thiolase are
Cys125, Asn343, His375, and
Cys403. Thiolase Asn343 and Cys403
are labeled in parentheses.
-carbons.
The electron density reveals a covalent attachment of the acetyl moiety
to Cys112 (bond distance, 1.8 Å), indicating that the
substrate was turned over by the enzyme to yield an initial product
complex. This is direct evidence that Cys112 is the
catalytic nucleophile. The acetyl oxygen makes hydrogen bonds to the
backbone nitrogens of Gly306 (2.8 Å) and
Cys112 (3.0 Å). These backbone nitrogens are ideal for
stabilizing the oxyanion formed during the transition state of acetyl
transfer. The same role can be suggested for the backbone nitrogens of
Phe400 and Cys163 of FabF by structural
analogy. FabH Ala113 has a slightly unfavorable torsion
angle, which may be required to make Cys112 N available for
the interaction. The acetyl methyl group occupies a hydrophobic pocket
in the active site, formed by the side chains of Leu142,
Phe157, Leu189, Leu205, and
Phe87', which belongs to the other monomer (Fig.
5A). The van der Waals interactions between the acetyl methyl and Phe87' suggest
that the dimer interface plays a critical role in determining the
primer specificity of FabH.

View larger version (32K):
[in a new window]
Fig. 5.
Substrate binding and structure of the active
site. A, stereo view of the acetyl binding pocket in
the active site. Atom colors are as defined as follows: carbon,
yellow; nitrogen, blue; oxygen, red;
and sulfur, green. The acetyl group is shown with
red bonds, whereas the dashed lines indicate
hydrogen bonds. Phe87 of the other monomer in the FabH
dimer is labeled as Phe87' and is shown in
magenta. For clarity, only the mercaptoethylamine group of
CoA is shown, which is drawn with green bonds. B,
electron density of the bound CoA molecule. Atom colors are as defined
before, with the three phosphorous atoms in blue as well.
The map is contoured at 1
. C, adenine binding site.
Protein residues are in yellow bonds, and the CoA molecule
is drawn in purple bonds. Carbon atoms are drawn in
yellow, nitrogens in blue, oxygens in
red, and phosphors in purple. The dashed
lines denote hydrogen bonds.
-mercaptoethylamine tail of CoA is
flexible, as indicated by the weak electron density and the lack of
specific protein interactions. Cys112 is at the bottom of
this cavity, with the acetyl carbon 3.9 Å away from the CoA sulfur
atom (Fig. 5A).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (32K):
[in a new window]
Fig. 6.
Proposed mechanism of the FabH
reactions. A, schematic diagram of the acetylation
reaction mechanism. Dotted lines indicate hydrogen bonds;
thick arrows indicate attack or electron transfer
directions. His244 extracts a proton from
Cys112, which may then attack the carbonyl of acetyl-CoA.
The tetrahedral intermediate is stabilized by backbone nitrogens of
Gly306 and Cys112. His244 may
donate a proton at the end of acetylation to form a neutral CoA.
B, FabH surface charge distribution viewed toward the active
site cavity. The figure was calculated with the acetyl-CoA complex
structure after removing the bound CoA. Only the monomer was used,
because the dimer interface is not in the area of interest.
Red indicates negative potential, and blue
indicates positive potential. The CoA molecule is shown to occupy the
active site, with white for carbon atoms, blue
for nitrogens, red for oxygens, yellow for
phosphors, and green for the sulfur. C, proposed
structural basis for the decarboxylation and condensation mechanisms.
According to the mechanism (14), the carboxylic acid moiety probably
binds His244, whereas the carbonyl group interacts with
Asn274. The decarboxylation produces a carbanion, which
resonates with an enol intermediate that is stabilized by
Asn274. The nucleophilic attack from the carbanion to the
enzyme-bound acetyl group leads to a tetrahedral intermediate and
finally yields the product acetoacetyl-ACP.
The observed active site cavity appears to be the only access to Cys112 and, therefore, the possible binding cavity for the second substrate malonyl-ACP and the feedback inhibitor palmitoyl-ACP. Malonyl-ACP is a common substrate for many condensing enzymes. The phosphopantetheine group is linked to a serine of the ACP, which is an acidic protein of 78 residues (27). A region above the FabH cavity is positively charged and seems to be suitable for ACP binding (Fig. 6B). This region mainly includes two helices (Ca1 and Ca2) and contains several positively charged residues (Arg36, Arg40, Lys214, His222, Arg235, Arg249, Lys256, and Lys257). Binding of the prosthetic group of malonyl-ACP may be modeled based on the bound CoA. This is reasonable given that the acetylated FabH is known to react with ACP to produce acetyl-ACP (6), which is the reverse of the acetyl transfer reaction and a good indication that CoA and ACP can bind FabH similarly in the pantothenate region.
The acetyl transfer reaction is clearly a distinct step in the FabH
reaction. A stepwise mechanism has also been proposed for
decarboxylation and condensation (14, 28). FabH can catalyze the
production of acetyl-ACP from butyryl-CoA and malonyl-ACP (8), further
suggesting that decarboxylation need not occur in concert with
condensation. The active sites are very similar between the apo and
acetylated structures; only His244 shifts marginally (0.5 Å). However, it is known that malonyl-ACP only binds acetylated FabH
but not the apo form of the enzyme (7, 8). This suggests that either
the acetyl group interacts directly with the malonyl moiety, or the
change of Cys112 electrostatic potential upon acetylation
is important for the binding of this substrate. The former is unlikely
because iodoacetamide can also induce the binding of the malonyl group
(29). The latter is probably true because His244 is
counterbalanced by Cys112 in apo FabH (Fig. 6A)
but is available in acetylated FabH for a charged interaction with the
malonyl carboxylic acid (Fig. 6C). His244 is the
only potentially positively charged residue in the active site, which
provides another reason for the proposed His244-carboxylic
acid interaction during decarboxylation. In addition, His244 may stabilize the carbanion for the nucleophilic
attack and donate a proton to Cys112 after condensation.
Modeling clearly suggests that Asn274 forms a hydrogen bond
with the malonyl carbonyl oxygen. Therefore, Asn274 may
promote decarboxylation by general acid catalysis via stabilizing an
enol intermediate (Fig. 6C) and hold the carbanion for
nucleophilic attack in condensation. Other condensing enzymes use a
histidine in that position, and the histidine is suitable to play these same roles of Asn274. Based on our structures, mutagenesis
and biochemical experiments can be devised to test these models and
their application in other condensing enzymes. The structure will also
facilitate the structure-based design of novel antibiotic drugs against
this important target.
| |
ACKNOWLEDGEMENTS |
|---|
We thank the Advanced Photon Source Industrial Macromolecular Crystallography Association-Collaborative Access Team staff and the National Synchrotron Light Source X12C staff for assistance in data collection, Kathleen Maley for help in E. coli transformation, Dean McNulty for N-terminal sequence analysis, Dr. David Tew for insightful discussions, and Drs. Robert Daines, Bill Kingsbury, Marti Head, John Elliot, John Gleason, Christine Debouck, Jim Kane, and Glen Van Aller for encouragement.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1D9B) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
To whom correspondence should be addressed. Tel.: 610-270-4589;
Fax: 610-270-4091; E-mail: xiayang_qiu-1@sbphrd.com.
2 J. Lonsdale, unpublished data.
3 A. Konstandinidis, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
ACP, acyl-carrier
protein;
FabH,
-ketoacyl-ACP synthase III;
FabF,
-ketoacyl-ACP
synthase II;
r.m.s., root mean square.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Cronan, J. E., Jr., and Rock, C. O. (1996) in E. coli and Salmonella, Cellular and Molecular Biology (Neidhardt, F. C., ed) , pp. 612-638, ASM Press, Washington, D. C. |
| 2. |
Magnuson, K.,
Jackowski, S.,
Rock, C. O.,
and Cronan, J. E.
(1993)
Microbiol. Rev.
57,
522-542 |
| 3. | Hopwood, D. A., and Sherman, D. H. (1990) Annu. Rev. Genet. 24, 37-66[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Cane, D. E.,
Walsh, C. T.,
and Khosla, C.
(1998)
Science
282,
63-68 |
| 5. |
McDaniel, R.,
Thamchaipenet, A.,
Gustafsson, C.,
Fu, H.,
Betlach, M.,
and Ashley, G.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1846-1851 |
| 6. |
Tsay, J. T.,
Oh, W.,
Larson, T. J.,
Jakowski, S.,
and Rock, C. O.
(1992)
J. Biol. Chem.
267,
6807-6814 |
| 7. |
Heath, R. J.,
and Rock, C. O.
(1996)
J. Biol. Chem.
271,
1833-1836 |
| 8. |
Heath, R. J.,
and Rock, C. O.
(1996)
J. Biol. Chem.
271,
10996-11000 |
| 9. | Verwoert, I. I., van der Linden, K. H., Walsh, M. C., Nijkamp, H. J., and Stuitje, A. R. (1995) Plant Mol. Biol. 27, 875-876[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Han, L.,
Lobo, S.,
and Reynolds, K. A.
(1998)
J. Bacteriol.
180,
4481-4486 |
| 11. |
Clough, R. C.,
Matthis, A. L.,
Barnum, S. R.,
and Jaworski, J. G.
(1992)
J. Biol. Chem.
267,
20992-20998 |
| 12. |
Travis, J.
(1994)
Science
264,
360-362 |
| 13. | Stinson, S. C. (1996) Chem. Eng. News 74, 75-100 |
| 14. | Siggaard-Anderson, M. (1993) Protein Seq. Data Anal. 5, 325-335 |
| 15. | Omura, S. (1979) Bacteriol. Rev. 40, 681-697 |
| 16. | Terwilliger, T. C., and Berendzen, J. (1999) Acta Crystallogr. D 55, 849-861[CrossRef] |
| 17. | Brunger, A. T. (1993) X-PLOR Version 3.1, A System for X-ray Crystallography and NMR , Yale University Press, New Haven |
| 18. | Collaborative Computational Project Number 4. (1994) Acta Cryst. D 50, 760-763 |
| 19. | McRee, D. E. (1993) Practical Protein Crystallography , Academic Press, San Diego |
| 20. | Kraulis, P. (1991) J. Appl. Crystallogr. 24, 946-950[CrossRef] |
| 21. | Nicholls, A., and Honig, B. H. (1991) J. Comp. Chem. 12, 435-445[CrossRef] |
| 22. | Huang, W., Jia, J., Edwards, P., Dehesh, K., Schneider, G., and Lindqvist, Y. (1998) EMBO J. 17, 1183-1191[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Moche, M.,
Schneider, G.,
Edwards, P.,
Dehesh, K.,
and Lindqvist, Y.
(1999)
J. Biol. Chem.
274,
6031-6034 |
| 24. | Mathieu, M., Zeelen, J. P., Pauptit, R. A., Erdmann, R., Kunau, W. H., and Wierenga, R. K. (1994) Structure 2, 797-808[Medline] [Order article via Infotrieve] |
| 25. | Mathieu, M., Modis, Y., Zeelen, J. P., Engel, C. K., Abagyan, R. A., Ahlberg, A., Rasmussen, B., Lamzin, V. S., Kunau, W. H., and Wierenga, R. K. (1997) J. Mol. Biol. 273, 714-728[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Qiu, X., Culp, J. S., DiLella, A. G., Hellmig, B., Hoog, S. S., Janson, C. A., Smith, W. W., and Abdel-Meguid, S. S. (1996) Nature 383, 275-279[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Mayo, K. H., and Prestegard, J. H. (1985) Biochemistry 24, 7834-7838[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Clark, J. D., O'Keefe, S. J., and Knowles, J. R. (1988) Biochemistry 27, 5961-5971[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Kresze, G. B., Steber, L., Oesterhelt, D., and Lynen, F. (1977) Eur. J. Biochem. 79, 191-199[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
K. Fukuma, E. D. Neuls, J. M. Ryberg, D.-Y. Suh, and U. Sankawa Mutational Analysis of Conserved Outer Sphere Arginine Residues of Chalcone Synthase J. Biochem., December 1, 2007; 142(6): 731 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Zhang, J. Hurlbert, S. W. White, and C. O. Rock Roles of the Active Site Water, Histidine 303, and Phenylalanine 396 in the Catalytic Mechanism of the Elongation Condensing Enzyme of Streptococcus pneumoniae J. Biol. Chem., June 23, 2006; 281(25): 17390 - 17399. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Brown, S. Sridharan, L. Kremer, S. Lindenberg, L. G. Dover, J. C. Sacchettini, and G. S. Besra Probing the Mechanism of the Mycobacterium tuberculosis {beta}-Ketoacyl-Acyl Carrier Protein Synthase III mtFabH: FACTORS INFLUENCING CATALYSIS AND SUBSTRATE SPECIFICITY J. Biol. Chem., September 16, 2005; 280(37): 32539 - 32547. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qiu, A. E. Choudhry, C. A. Janson, M. Grooms, R. A. Daines, J. T. Lonsdale, and S. S. Khandekar Crystal structure and substrate specificity of the {beta}-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus Protein Sci., August 1, 2005; 14(8): 2087 - 2094. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, G. Florova, and K. A. Reynolds Alteration of the Fatty Acid Profile of Streptomyces coelicolor by Replacement of the Initiation Enzyme 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH) J. Bacteriol., June 1, 2005; 187(11): 3795 - 3799. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Theisen, I. Misra, D. Saadat, N. Campobasso, H. M. Miziorko, and D. H. T. Harrison From the Cover: 3-hydroxy-3-methylglutaryl-CoA synthase intermediate complex observed in "real-time" PNAS, November 23, 2004; 101(47): 16442 - 16447. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Campobasso, M. Patel, I. E. Wilding, H. Kallender, M. Rosenberg, and M. N. Gwynn Staphylococcus aureus 3-Hydroxy-3-methylglutaryl-CoA Synthase: CRYSTAL STRUCTURE AND MECHANISM J. Biol. Chem., October 22, 2004; 279(43): 44883 - 44888. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Austin, M. Izumikawa, M. E. Bowman, D. W. Udwary, J.-L. Ferrer, B. S. Moore, and J. P. Noel Crystal Structure of a Bacterial Type III Polyketide Synthase and Enzymatic Control of Reactive Polyketide Intermediates J. Biol. Chem., October 22, 2004; 279(43): 45162 - 45174. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. He, A. M. Reeve, U. R. Desai, G. E. Kellogg, and K. A. Reynolds 1,2-Dithiole-3-Ones as Potent Inhibitors of the Bacterial 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH) Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3093 - 3102. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Nomura, K. Taguchi, S. Taguchi, and Y. Doi Coexpression of Genetically Engineered 3-Ketoacyl-ACP Synthase III (fabH) and Polyhydroxyalkanoate Synthase (phaC) Genes Leads to Short-Chain-Length-Medium-Chain-Length Polyhydroxyalkanoate Copolymer Production from Glucose in Escherichia coli JM109 Appl. Envir. Microbiol., February 1, 2004; 70(2): 999 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Price, C. O. Rock, and S. W. White The 1.3-Angstrom-Resolution Crystal Structure of {beta}-Ketoacyl-Acyl Carrier Protein Synthase II from Streptococcus pneumoniae J. Bacteriol., July 15, 2003; 185(14): 4136 - 4143. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Misra, C.-Z. Wang, and H. M. Miziorko The Influence of Conserved Aromatic Residues in 3-Hydroxy-3-methylglutaryl-CoA Synthase J. Biol. Chem., July 11, 2003; 278(29): 26443 - 26449. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nowak-Thompson, P. E. Hammer, D. S. Hill, J. Stafford, N. Torkewitz, T. D. Gaffney, S. T. Lam, I. Molnar, and J. M. Ligon 2,5-Dialkylresorcinol Biosynthesis in Pseudomonas aurantiaca: Novel Head-to-Head Condensation of Two Fatty Acid-Derived Precursors J. Bacteriol., February 1, 2003; 185(3): 860 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. He and K. A. Reynolds Purification, Characterization, and Identification of Novel Inhibitors of the {beta}-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) from Staphylococcus aureus Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1310 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Funa, Y. Ohnishi, Y. Ebizuka, and S. Horinouchi Properties and Substrate Specificity of RppA, a Chalcone Synthase-related Polyketide Synthase in Streptomyces griseus J. Biol. Chem., February 8, 2002; 277(7): 4628 - 4635. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atanassov, L. Pezennec, J. d'Alayer, G. Grollier, B. Picard, and J.-L. Fauchere Novel Antigens of Helicobacter pylori Correspond to Ulcer-Related Antibody Pattern of Sera from Infected Patients J. Clin. Microbiol., February 1, 2002; 40(2): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Schujman, K.-H. Choi, S. Altabe, C. O. Rock, and D. de Mendoza Response of Bacillus subtilis to Cerulenin and Acquisition of Resistance J. Bacteriol., May 15, 2001; 183(10): 3032 - 3040. [Abstract] [Full Text] |
||||
![]() |
N. Smirnova and K. A. Reynolds Engineered Fatty Acid Biosynthesis in Streptomyces by Altered Catalytic Function of {beta}-Ketoacyl-Acyl Carrier Protein Synthase III J. Bacteriol., April 1, 2001; 183(7): 2335 - 2342. [Abstract] [Full Text] |
||||
![]() |
K.-H. Choi, L. Kremer, G. S. Besra, and C. O. Rock Identification and Substrate Specificity of beta -Ketoacyl (Acyl Carrier Protein) Synthase III (mtFabH) from Mycobacterium tuberculosis J. Biol. Chem., September 1, 2000; 275(36): 28201 - 28207. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Price, K.-H. Choi, R. J. Heath, Z. Li, S. W. White, and C. O. Rock Inhibition of beta -Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin. STRUCTURE AND MECHANISM J. Biol. Chem., February 23, 2001; 276(9): 6551 - 6559. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Zhang, M. S. Rao, R. J. Heath, A. C. Price, A. J. Olson, C. O. Rock, and S. W. White Identification and Analysis of the Acyl Carrier Protein (ACP) Docking Site on beta -Ketoacyl-ACP Synthase III J. Biol. Chem., March 9, 2001; 276(11): 8231 - 8238. [Abstrac |